Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | PDE1A | P54750 | 4/20 | 0.34 |
| ▸ | PDE1B | Q01064 | 4/20 | 0.34 |
| ▸ | PDE1C | Q14123 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23251410 | 0.83 | HPGD (0.39) | HPGDSMN1; SMN2LRRK2GRM5PDE1A | |
| SCHEMBL7598688 | 0.78 | HPGD (0.52) | HPGDSMN1; SMN2LRRK2GRM5ALDH1A1 | |
| SCHEMBL29483319 | 0.77 | CYP2D6 (0.38) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL111252 | 0.77 | CYP2D6 (0.38) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL27305156 | 0.76 | LRRK2 (0.36) | LRRK2ALDH1A1KMT2AMEN1L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL28789679 | 0.76 | HPGD (0.50) | HPGDSMN1; SMN2LRRK2GRM5ALDH1A1 | |
| SCHEMBL2732228 | 0.72 | PIK3CG (0.31) | — | |
| SCHEMBL9166315 | 0.72 | CCR4 (0.33) | HPGDSMN1; SMN2KMT2AMEN1NQO1 | |
| SCHEMBL22193276 | 0.71 | HPGD (0.37) | HPGDSMN1; SMN2 | |
| SCHEMBL11951662 | 0.71 | PDE1A (0.44) | HPGDSMN1; SMN2PDE1APDE1BPDE1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11504443-B2 | Odor-modulating agent and odor-modulating method | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2022-11-22 | — | — | US | claimed |
| US-11399558-B2 | Rebaudioside-D containing sweetener compositions | HEARTLAND CONSUMER PRODUCTS LLC (US) | 2022-08-02 | — | — | US | claimed |
| US-11365370-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-21 | — | — | US | claimed |
| CN-111565764-A | Odor conversion agent for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating, and odor conversion method for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating | 山本香料株式会社 | 2020-08-21 | — | — | CN | claimed |
| EP-3264917-B1 | REBAUDIOSIDE-D CONTAINING SWEETENER COMPOSITIONS | HEARTLAND CONSUMER PRODUCTS LLC (US) | 2020-06-24 | — | — | EP | claimed |
| US-20190175777-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2019-06-13 | — | — | US | claimed |
| EP-3467078-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | Yamamoto Perfumery Co. Ltd. (JP) | 2019-04-10 | — | — | EP | claimed |
| US-9949911-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-24 | — | — | US | claimed |
| EP-3264917-A1 | REBAUDIOSIDE-D CONTAINING SWEETENER COMPOSITIONS | Heartland Consumer Products, LLC (US) | 2018-01-10 | — | — | EP | claimed |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-02 | — | — | US | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| EP-2068655-A1 | SOLID UNIT DOSE, SWEETENING COMPOSITIONS | McNeil Nutritionals, LLC (US) | 2009-06-17 | — | — | EP | claimed |
| EP-1931219-A2 | SWEETENER AND AROMA COMPOSITIONS | McNeil Nutritionals, LLC (US) | 2008-06-18 | — | — | EP | claimed |
| WO-2008036234-A1 | SOLID UNIT DOSE, SWEETENING COMPOSITIONS | MCNEIL NUTRITIONALS, LLC (US) | 2008-03-27 | — | — | WO | claimed |
| US-20080069939-A1 | SOLID, UNIT DOSE, SWEETENING COMPOSITIONS | MCNEIL NUTRITIONALS, LLC | 2008-03-20 | — | — | US | claimed |
| WO-2007033066-A2 | SWEETENER AND AROMA COMPOSITIONS | MCNEIL NUTRITIONALS, LLC (US) | 2007-03-22 | — | — | WO | claimed |
| US-20070059420-A1 | Sweetener and aroma compositions | MCNEIL NUTRITIONALS, LLC | 2007-03-15 | — | — | US | claimed |
| US-20070059418-A1 | Self-mixing tabletop sweetener | MCNEIL NUTRITIONALS, LLC | 2007-03-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | HPGD 291/4885SMN1; SMN2 4196/4885LRRK2 4842/4885 |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | LPO, GPX4, DEK | HPGD 291/4885SMN1; SMN2 4196/4885LRRK2 4842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.